Drug Trial Radar · NCT04184622
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Last checked: Nov 20, 2026Latest source record: Jul 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,539
Actual
Start
Dec 4, 2019
Primary completion
Apr 1, 2022
Study completion Jul 6, 2024
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Dec 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weight. The study has two phases: A main phase and an extension phase. The main phase of the study will last 72 weeks. Participants with prediabetes will continue in the extension for another 2 years.
Conditions
- Overweight
- Obesity
Interventions
TirzepatideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Body Weight (Primary Treatment Period)Time frame: Baseline, Week 72
- Percentage of Participants Who Achieve ≥5% Body Weight Reduction (Primary Treatment Period)Time frame: Week 72
Locations
118 sites in 10 countries. Site status is shown where the registry gives one.
Cahaba Research
Pelham, Alabama
Perseverance Research Center
Scottsdale, Arizona
John Muir Physician Network Clinical Research Center
Concord, California
Valley Research
Fresno, California
National Research Institute - Wilshire
Los Angeles, California
Catalina Research Institute, LLC
Montclair, California
Encompass Clinical Research
Spring Valley, California
University Clinical Investigators, Inc.
Tustin, California
Yale University School of Medicine
New Haven, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut
Suncoast Research Group
Miami, Florida
New Horizon Research Center
Miami, Florida
Renstar Medical Research
Ocala, Florida
Oviedo Medical Research
Oviedo, Florida
ForCare Clinical Research
Tampa, Florida
Center for Advanced Research & Education
Gainesville, Georgia
Herman Clinical Research
Suwanee, Georgia
SKY Integrative Medical Center/SKYCRNG
Union City, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Midwest Institute for Clinical Research
Indianapolis, Indiana
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas
L-MARC Research Center
Louisville, Kentucky
NECCR PrimaCare Research
Fall River, Massachusetts
ActivMed Practices and Research
Methuen, Massachusetts
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan
StudyMetrix Research
City of Saint Peters, Missouri
Clinvest Research LLC
Springfield, Missouri
Palm Research Center Sunset
Las Vegas, Nevada
Premier Research
Trenton, New Jersey
NYU Langone Health
New York, New York
Weill Cornell Medical College
New York, New York
Rochester Clinical Research, LLC
Rochester, New York
University of North Carolina Medical Center
Chapel Hill, North Carolina
PharmQuest
Greensboro, North Carolina
Lillestol Research
Fargo, North Dakota
Velocity Clinical Research, Cleveland
Cleveland, Ohio
Aventiv Research Inc
Columbus, Ohio
Alliance for Multispecialty Research, LLC
Norman, Oklahoma
Summit Research Network
Portland, Oregon
Showing 40 of 118 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.